DE3885688T2 - Cephemverbindungen und Verfahren zu ihrer Herstellung. - Google Patents

Cephemverbindungen und Verfahren zu ihrer Herstellung.

Info

Publication number
DE3885688T2
DE3885688T2 DE88114722T DE3885688T DE3885688T2 DE 3885688 T2 DE3885688 T2 DE 3885688T2 DE 88114722 T DE88114722 T DE 88114722T DE 3885688 T DE3885688 T DE 3885688T DE 3885688 T2 DE3885688 T2 DE 3885688T2
Authority
DE
Germany
Prior art keywords
processes
preparation
cephem compounds
cephem
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE88114722T
Other languages
English (en)
Other versions
DE3885688D1 (de
Inventor
Kazuo Sakane
Kohji Kawabata
Kenzi Miyai
Yoshiko Inamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878721568A external-priority patent/GB8721568D0/en
Priority claimed from GB888815361A external-priority patent/GB8815361D0/en
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE3885688D1 publication Critical patent/DE3885688D1/de
Publication of DE3885688T2 publication Critical patent/DE3885688T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE88114722T 1987-09-14 1988-09-09 Cephemverbindungen und Verfahren zu ihrer Herstellung. Expired - Fee Related DE3885688T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878721568A GB8721568D0 (en) 1987-09-14 1987-09-14 Cephem compounds
GB888815361A GB8815361D0 (en) 1988-06-28 1988-06-28 New cephem compound & process for preparation thereof

Publications (2)

Publication Number Publication Date
DE3885688D1 DE3885688D1 (de) 1993-12-23
DE3885688T2 true DE3885688T2 (de) 1994-04-07

Family

ID=26292732

Family Applications (1)

Application Number Title Priority Date Filing Date
DE88114722T Expired - Fee Related DE3885688T2 (de) 1987-09-14 1988-09-09 Cephemverbindungen und Verfahren zu ihrer Herstellung.

Country Status (22)

Country Link
US (1) US4952578A (de)
EP (1) EP0307804B1 (de)
JP (1) JPH01151589A (de)
KR (1) KR0133560B1 (de)
CN (1) CN1024669C (de)
AU (1) AU617358B2 (de)
CA (1) CA1338842C (de)
DE (1) DE3885688T2 (de)
DK (1) DK509988A (de)
ES (1) ES2061581T3 (de)
FI (1) FI92322C (de)
HK (1) HK18396A (de)
HU (1) HU211830A9 (de)
IE (1) IE63094B1 (de)
IL (1) IL87731A (de)
NO (1) NO171853C (de)
NZ (1) NZ226143A (de)
OA (1) OA09014A (de)
PH (1) PH24719A (de)
PT (1) PT88481B (de)
RU (1) RU1787158C (de)
UA (1) UA41865C2 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194432A (en) * 1985-11-22 1993-03-16 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US5162520A (en) * 1986-09-22 1992-11-10 Fujisawa Pharmaceutical Co., Ltd. Intermediates for cephem compounds
CA1293719C (en) * 1986-09-22 1991-12-31 Takao Takaya Cephem compounds and processes for preparation thereof
US5663163A (en) * 1987-09-07 1997-09-02 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds and processes for preparation thereof
GB8905301D0 (en) * 1989-03-08 1989-04-19 Fujisawa Pharmaceutical Co New cephem compound and a process for preparation thereof
EP0517041A1 (de) * 1991-06-07 1992-12-09 Fujisawa Pharmaceutical Co., Ltd. Cephemverbindungen
NZ529887A (en) * 2001-05-01 2005-05-27 Fujisawa Pharmaceutical Co Cephem compounds
KR100463920B1 (ko) * 2002-10-18 2004-12-30 제일약품주식회사 신규 세프디토렌 피복실 메지틸렌 설폰산염 및 그 제조방법
JP4448821B2 (ja) * 2002-10-30 2010-04-14 アステラス製薬株式会社 セフェム化合物
AU2003902380A0 (en) * 2003-05-16 2003-06-05 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
DE602004026451D1 (de) * 2003-09-18 2010-05-20 Astellas Pharma Inc Cephem-verbindungen
CN1321109C (zh) * 2003-11-07 2007-06-13 天津药物研究院 一种头孢烯类鎓盐化合物及其制备方法和以该化合物合成硫酸头孢吡唑的方法
CN101747348B (zh) * 2008-12-11 2013-02-06 石药集团中奇制药技术（石家庄）有限公司 一种硫酸头孢噻利晶型及其制备方法
CN101781318B (zh) * 2010-02-26 2013-07-31 烟台宝华生物技术有限公司 头孢母核衍生化合物、由其制备的头孢烯类鎓盐化合物及采用其制备硫酸头孢吡唑的方法
CN101830913B (zh) * 2010-04-09 2012-10-31 烟台宝华生物技术有限公司 头孢母核衍生化合物、由其制备的头孢烯类鎓盐化合物及采用其制备硫酸头孢吡唑的方法
CN101993450B (zh) * 2010-11-03 2011-11-30 湖南欧亚生物有限公司 一种硫酸头孢噻利的制备方法
CN102336771A (zh) * 2011-07-11 2012-02-01 珠海联邦制药股份有限公司 一种硫酸头孢噻利中间体的制备方法
JP6151257B2 (ja) 2011-09-09 2017-06-21 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． 肺内感染症の治療方法
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
CN102875572B (zh) * 2012-10-26 2014-07-30 四川科伦药物研究有限公司 一种硫酸头孢噻利中间体的精制方法
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US20140274993A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane-tazobactam pharmaceutical compositions
EP3100732A1 (de) 2013-03-15 2016-12-07 Merck Sharp & Dohme Corp. Antibiotische ceftolozanzusammensetzungen
US10376496B2 (en) 2013-09-09 2019-08-13 Merck, Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR63088B (en) * 1976-04-14 1979-08-09 Takeda Chemical Industries Ltd Preparation process of novel cephalosporins
GB2037281B (en) * 1978-11-15 1983-01-19 Glaxo Group Ltd 7( -(2-amino-4-thiozolyl)-2-hydroximino-acetanuds)-cephalosporins
JPS584789A (ja) * 1981-04-03 1983-01-11 Fujisawa Pharmaceut Co Ltd 新規セフエム化合物およびその製造法
EP0062321B1 (de) * 1981-04-03 1989-03-01 Fujisawa Pharmaceutical Co., Ltd. Cephalosporinderivate, Verfahren zu ihrer Herstellung, sie enthaltende pharmazeutische Präparate und ihre Ausgangsprodukte
US4401668A (en) * 1981-10-02 1983-08-30 Eli Lilly And Company Pyrazinium substituted cephalosporins
ATE82976T1 (de) * 1985-09-03 1992-12-15 Otsuka Kagaku Kk Cephalosporinderivate.
DE3539901A1 (de) * 1985-11-11 1987-05-14 Hoechst Ag Cephalosporinderivate und verfahren zu ihrer herstellung
CN86107947A (zh) * 1985-11-22 1987-05-27 藤沢药品工业株式会社 新的头孢烯化合物及其制备方法

Also Published As

Publication number Publication date
HK18396A (en) 1996-02-09
DK509988D0 (da) 1988-09-13
IL87731A0 (en) 1989-02-28
CN1032540A (zh) 1989-04-26
CN1024669C (zh) 1994-05-25
IE63094B1 (en) 1995-03-22
EP0307804A2 (de) 1989-03-22
FI884193A0 (fi) 1988-09-13
US4952578A (en) 1990-08-28
FI884193A (fi) 1989-03-15
KR890005124A (ko) 1989-05-11
JPH0576950B2 (de) 1993-10-25
AU617358B2 (en) 1991-11-28
NO884058L (no) 1989-03-15
EP0307804A3 (en) 1989-11-08
IE882692L (en) 1989-03-14
KR0133560B1 (ko) 1998-04-23
DE3885688D1 (de) 1993-12-23
EP0307804B1 (de) 1993-11-18
HU211830A9 (en) 1995-12-28
CA1338842C (en) 1997-01-14
RU1787158C (ru) 1993-01-07
DK509988A (da) 1989-03-15
NO171853C (no) 1993-05-12
JPH01151589A (ja) 1989-06-14
FI92322C (fi) 1994-10-25
AU2227188A (en) 1989-03-16
NZ226143A (en) 1990-11-27
ES2061581T3 (es) 1994-12-16
NO171853B (no) 1993-02-01
NO884058D0 (no) 1988-09-13
IL87731A (en) 1993-05-13
FI92322B (fi) 1994-07-15
UA41865C2 (uk) 2001-10-15
OA09014A (fr) 1991-03-31
PH24719A (en) 1990-10-01
PT88481A (pt) 1988-10-01
PT88481B (pt) 1992-11-30

Similar Documents

Publication Publication Date Title
DE3885688T2 (de) Cephemverbindungen und Verfahren zu ihrer Herstellung.
DE3780263T2 (de) Imidazopyridinverbindungen und verfahren zu ihrer herstellung.
DE3689684D1 (de) Cephemverbindungen und Verfahren zu ihrer Herstellung.
DE3789243D1 (de) Naphthalocyaninverbindungen und Verfahren zu ihrer Herstellung.
DE3850363D1 (de) Carboxymethylsulfoethylcellulose und Verfahren zu ihrer Herstellung.
PT86826A (pt) Kristallisierte cephem-saeureadditionssalze und verfahren zu ihrer herstellung
DE69106627D1 (de) Oligohexafluorpropylenverbindungen und Verfahren zu ihrer Herstellung.
DE68923993D1 (de) Polymaleimid-Verbindungen und Verfahren zu ihrer Herstellung.
DE3879335T2 (de) Trifluorbenzolverbindungen und verfahren zu ihrer herstellung.
DE3786452T2 (de) Benzylether-Verbindungen und Verfahren zu ihrer Herstellung.
DE3884551T2 (de) Radioaktive Benzodiazepinderivate und Verfahren zu ihrer Herstellung.
DE69006071T2 (de) Bronchospasmolytische Verbindungen und Verfahren zu ihrer Herstellung.
DE3880490T2 (de) Perfluoramino-oxaziridine und Verfahren zu ihrer Herstellung.
DE69017091D1 (de) Cyclomalto-oligosaccharidderivate und Verfahren zu ihrer Herstellung.
DE3788489D1 (de) Fe7C3-enthaltende Partikel und Verfahren zu ihrer Herstellung.
DE69010086T2 (de) Organosiliciumverbindungen und Verfahren zu ihrer Herstellung.
DE68914500T2 (de) Alkylarylsulfone und Verfahren zu ihrer Herstellung.
DE3688287T4 (de) Spirodiphosphoamidatverbindungen und Verfahren zu ihrer Herstellung.
DE68914893D1 (de) Fluorierte Verbindungen und Verfahren zu ihrer Herstellung.
ATE97416T1 (de) Cephemverbindungen und verfahren zu ihrer herstellung.
DE69017290D1 (de) Organosiliciumverbindungen und Verfahren zu ihrer Herstellung.
PT86889A (pt) Cephalosporinderivate und verfahren zu ihrer herstellung
DE3852459T2 (de) Beta-lactam-Verbindung und Verfahren zu ihrer Herstellung.
ATE78035T1 (de) Imidazopyridinverbindungen und verfahren zu ihrer herstellung.
ATE102209T1 (de) Cephemverbindungen und verfahren zu ihrer herstellung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee